<SEC-DOCUMENT>0001292814-25-003098.txt : 20250818
<SEC-HEADER>0001292814-25-003098.hdr.sgml : 20250818
<ACCEPTANCE-DATETIME>20250815175818
ACCESSION NUMBER:		0001292814-25-003098
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250930
FILED AS OF DATE:		20250818
DATE AS OF CHANGE:		20250815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRASKEM SA
		CENTRAL INDEX KEY:			0001071438
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14862
		FILM NUMBER:		251225827

	BUSINESS ADDRESS:	
		STREET 1:		RUA ETEND NO 1561
		CITY:			CAMARACI BAHIA BRAZIL
		STATE:			D5
		ZIP:			42810-000
		BUSINESS PHONE:		011551134439744

	MAIL ADDRESS:	
		STREET 1:		RUA ETENO NO 1561
		CITY:			CAMACARI BAHIA BRAZI
		STATE:			D5
		ZIP:			42810-000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COPENE PETROQUIMICA DO NORDESTE SA
		DATE OF NAME CHANGE:	20000428
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>bak20250814_6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>

<HR SIZE="2" NOSHADE ALIGN="LEFT" COLOR="Black" STYLE="width: 100%">
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 25%; color: black">

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13A-16<BR>
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><BR>
For the month of August, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><B>(Commission File No. 1-14862 )</B></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 25%; color: black">

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>BRASKEM S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Exact Name as Specified in its Charter)</I></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Translation of registrant's name into English)</I></P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 25%; color: black">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Rua Eteno, 1561, Polo Petroquimico de Camacari<BR>
Camacari, Bahia - CEP 42810-000 Brazil</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Address of principal executive offices)</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 25%; color: black">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.<BR>
<BR>
Form 20-F ___X___ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F ______</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Indicate by check mark if the registrant is
submitting the Form 6-K<BR>
in paper as permitted by Regulation S-T Rule 101(b)(1). _____</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Indicate by check mark if the registrant is
submitting the Form 6-K<BR>
in paper as permitted by Regulation S-T Rule 101(b)(7). _____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center">Indicate by check mark whether the
registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.<BR>
<BR>
Yes ______ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No ___X___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">If &quot;Yes&quot; is marked, indicate below
the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 3pt 0; text-align: justify; text-indent: 206.65pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt/115% Tahoma, Helvetica, Sans-Serif; margin-top: 3pt; margin-bottom: 3pt; text-align: center; color: #7F7F7F"><IMG SRC="bak202508146k_002.jpg" ALT="">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt Tahoma, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/115% Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 10pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="width: 90%; text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">1.&nbsp;&nbsp;&nbsp;PURPOSE</TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 6pt; padding-bottom: 12pt">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">2.&nbsp;&nbsp;&nbsp;SCOPE</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">3.&nbsp;&nbsp;&nbsp;REFERENCES</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">4.&nbsp;&nbsp;&nbsp;DUTIES AND RESPONSIBILITIES</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">4.1&nbsp;&nbsp;&nbsp;SHAREHOLDERS MEETING</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">4.2&nbsp;&nbsp;&nbsp;BOARD OF DIRECTORS (&ldquo;Board&rdquo; or &ldquo;BoD&rdquo;)</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">4.3&nbsp;&nbsp;&nbsp;STATUTORY COMPLIANCE AND AUDIT COMMITTEE</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">4.4&nbsp;&nbsp;&nbsp;CONTRACTING AREAS</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">4.5&nbsp;&nbsp;&nbsp;CORPORATE GOVERNANCE AREA</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">5.&nbsp;&nbsp;&nbsp;POLICY</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">5.1&nbsp;&nbsp;&nbsp;DEFINITION OF RELATED PARTIES OF BRASKEM</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">5.2&nbsp;&nbsp;&nbsp;IDENTIFICATION OF BRASKEM&rsquo;S RELATED PARTIES</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">6</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">5.3&nbsp;&nbsp;&nbsp;NEGOTIATION OF RELATED PARTY TRANSACTIONS</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">6</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">5.4&nbsp;&nbsp;&nbsp;ANALYSIS AND GOVERNANCE FOR THE APPROVAL OF RELATED PARTY TRANSACTIONS</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">7</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">5.5&nbsp;&nbsp;&nbsp;PROHIBITIONS</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">8</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">5.6&nbsp;&nbsp;&nbsp;DISCLOSURE OF RELATED PARTY TRANSACTIONS</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">8</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">5.7&nbsp;&nbsp;&nbsp;SITUATIONS INVOLVING POTENTIAL CONFLICTS OF INTEREST</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">9</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">6.&nbsp;&nbsp;&nbsp;GENERAL PROVISIONS</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">10</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 11pt Tahoma, Helvetica, Sans-Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; padding-top: 6pt; padding-bottom: 12pt; padding-left: 0in">DEFINITIONS</TD>
    <TD STYLE="text-align: right; padding-top: 6pt; padding-bottom: 12pt">11</TD></TR>
</TABLE>
<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0"><B><BR STYLE="clear: both">
&nbsp;</B></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; color: #404040; font: bold 12pt/115% Tahoma, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 3pt"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt/115% Tahoma, Helvetica, Sans-Serif; color: #404040; margin: 12pt 0 3pt; text-indent: 0in"><FONT STYLE="font-size: 11pt">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <FONT STYLE="font-size: 11pt">PURPOSE</FONT></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">This Policy establishes the
rules and procedures to be followed in transactions between, on one side, Braskem S.A. (&ldquo;<B>Braskem</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;)
and/or any of its Controlled Companies, and on the other side, any Related Parties of Braskem, as defined in this Policy (&ldquo;<B>Related
Parties</B>&rdquo;), to ensure that all transactions with Related Parties (&ldquo;<B>Related Party Transactions</B>&rdquo;) are conducted
under commutative conditions or with appropriate compensatory payment, and carried out with fairness and transparency, in the best interest
of the Company and in alignment with ESG best practices, particularly from a corporate governance perspective. This Policy also sets forth
procedures to be adopted to ensure impartiality in the decision-making process in situations that may involve potential conflicts of interest.</P>

<P STYLE="color: #404040; font: bold 12pt/115% Tahoma, Helvetica, Sans-Serif; margin: 12pt 0 3pt; text-indent: 0in"><FONT STYLE="font-size: 11pt">2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt">SCOPE</FONT></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">This Policy applies to Braskem
and must be observed by all its Controlled Companies, in Brazil and abroad, for the purposes of compliance with Braskem&rsquo;s governance
practices. Controlled Companies may approve their own policies, in compliance with local governance and legislation, provided that Braskem&rsquo;s
governance and the principles of this Policy are met and that there is no contradiction with its guidelines.</P>

<P STYLE="color: #404040; font: bold 12pt/115% Tahoma, Helvetica, Sans-Serif; margin: 12pt 0 3pt; text-indent: 0in"><FONT STYLE="font-size: 11pt">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt">REFERENCES</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">Braskem Bylaws </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">Braskem Code of Conduct </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">PE 1050-00020 &ndash; Global
Compliance System Policy </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">PE 1050-00021 &ndash; Braskem
Global Anticorruption Policy </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">PE 1030-00001 &ndash; Financial
Policy</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">Charters of the Board of Directors
of Braskem and its Advisory Committees</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">BRK-DIR-00-000368&nbsp;&ndash;&nbsp;Guideline
for Related Party Transactions</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">BRK-DIR-00-000350-PT &ndash;
Delegation of Authority</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: bold 12pt/115% Tahoma, Helvetica, Sans-Serif; margin: 12pt 0 3pt; text-indent: 0in"><FONT STYLE="font-size: 11pt">4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt">DUTIES AND RESPONSIBILITIES</FONT></P>

<P STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 11pt">4.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt">SHAREHOLDERS MEETING</FONT></P>

<P STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.75in; text-align: justify; text-indent: -25.65pt"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">Deliberate on Related Party Transactions when within
its scope of authority, under Federal Law 6,404/76 and CVM rules.</FONT></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 28.35pt; text-indent: 0in"><FONT STYLE="font-size: 11pt">4.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt">BOARD OF DIRECTORS (&ldquo;Board&rdquo; or &ldquo;BoD&rdquo;)</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 21.3pt">(a)</TD><TD STYLE="text-align: justify">To deliberate on Related Party Transactions that fall within its scope of authority, pursuant to the criteria
set forth in the Company&rsquo;s Bylaws; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 21.3pt">(b)</TD><TD STYLE="text-align: justify">To deliberate on amendments to the content of this Policy.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #7F7F7F; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 28.35pt; text-indent: 0in"><FONT STYLE="font-size: 11pt">4.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt">STATUTORY COMPLIANCE AND AUDIT COMMITTEE (&ldquo;CCAE&rdquo;)</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 25.65pt">(a)</TD><TD STYLE="text-align: justify">To assess, prior to the resolution by the Board of Directors, the adequacy of Related Party Transactions
subject to the Board&rsquo;s authority, pursuant to the criteria set forth in the Company&rsquo;s Bylaws, and to recommend or not their
execution;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 25.65pt">(b)</TD><TD STYLE="text-align: justify">To monitor Related Party Transactions entered into by the Company and/or any of its Controlled Companies
with any Related Parties of Braskem, whose approval does not fall under the authority of the Board of Directors;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 25.65pt">(c)</TD><TD STYLE="text-align: justify">To monitor compliance with the guidelines established in this Policy; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 25.65pt">(d)</TD><TD STYLE="text-align: justify">To assess, prior to the resolution by the Board of Directors, any amendments to the content of this Policy
and to propose improvements to its provisions when deemed necessary.</TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 11pt">4.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt">CONTRACTING AREAS</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 25.5pt">(a)</TD><TD STYLE="text-align: justify">To report to the Corporate Governance Area all Related Party Transactions whose approval does not fall
under the authority of the Board of Directors, by submitting the Related Party Form no later than the 5th business day of the month following
the transaction; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 25.5pt">(b)</TD><TD STYLE="text-align: justify">To report to the Corporate Legal Department and the Investor Relations Area, as soon as possible, when
spot or similar transactions (i.e., those not formalized through a specific contract) reach the threshold of R$50 million, to enable their
disclosure to the market, in accordance with the deadlines and terms set forth in CVM Resolution No. 80/22.</TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 28.35pt; text-indent: 0in"><FONT STYLE="font-size: 11pt">4.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt">CORPORATE GOVERNANCE AREA</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 21.25pt">(a)</TD><TD STYLE="text-align: justify">To prepare and keep updated, within the Company&rsquo;s internal systems, the List of Related Parties,
as well as to periodically share the List of Related Parties with the Controlled Companies; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 21.25pt">(b)</TD><TD STYLE="text-align: justify">To submit to the Statutory Compliance and Audit Committee, on a quarterly basis, for monitoring purposes,
a report consolidating the relevant information regarding Related Party Transactions carried out during the period, as reported by the
Contracting Areas.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: gray; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.3in; text-indent: 0in">&nbsp;</P>

<P STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-indent: 0in"><FONT STYLE="font-size: 11pt">5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt">POLICY</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.9pt"><FONT STYLE="font-size: 11pt">5.1</FONT></TD><TD><FONT STYLE="font-size: 11pt; text-transform: uppercase">DEFINITION OF RELATED PARTIES OF BRASKEM</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">A Related Party of Braskem
shall be understood as defined under CPC 05 (R1), as amended<B>:</B></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt"><B>(i)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt"><B>any individual in one of
the following situations:</B></FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">holds control of or Significant Influence over Braskem;
</FONT></P>

<P STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">is the Key Person of Braskem, of its controlling shareholder
or of the Controlled Companies, with the exception of entities under Braskem's joint control; or</FONT></P>

<P STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">is a Close Relative of any person indicated in the above
items.</FONT></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt"><B>(ii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt"><B>any legal or other entity
(even if unincorporated) in one of the following situations:</B></FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT>is a controlling shareholder of Braskem;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT>is a Subsidiary of Braskem (subject to the exceptions envisaged in this Policy);</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT>is under the shared control of Braskem, i.e., a subsidiary of Braskem&rsquo;s parent company;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT>holds Significant Influence over Braskem or is controlled by such entity;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT>is an Associated Company of Braskem;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT>is an Associated Company of Braskem&rsquo;s parent company;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT>is a post-employment benefit plan whose beneficiaries are the employees of Braskem or of such entity;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT>is controlled by a person identified in item (i) above;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>is under the Significant Influence of a person identified in item (i) above that holds control of Braskem;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT>has as its Key Person (or the Key Person of its parent company) a person identified in item (i) above that holds control over Braskem;
or</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 6pt 49.65pt; text-align: justify; text-indent: 0.25pt">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT>renders the services of key management personnel of Braskem or to the parent company of Braskem or is a member of a group of which
such supplier entity is a part.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; text-align: justify">In the classification
of a person as a Related Party, (i) any reference to an entity, regardless of its relationship with Braskem, includes the direct or indirect
subsidiaries of this entity; (ii) any reference to Braskem&rsquo;s parent company includes its direct or indirect controlling entities,
up to the level of an individual controlling shareholder, where applicable; and (iii) unless expressly stated otherwise in this Policy,
any reference to control, subsidiary, or parent company includes full or shared control (i.e., joint control with a third party).</P>
<P STYLE="font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; color: #404040; margin: 0 0 0 14.2pt; text-align: justify"></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; text-align: justify">The following shall
not be considered a Related Party:</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/17pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 14.2pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">an entity solely by virtue of
having a common Officer or Key Person with Braskem or any of its Controlled Companies, or by virtue of a Key Person of Braskem or any
of its Controlled Companies exercising Significant Influence over such entity; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/17pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 14.2pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">an entity solely by sharing
joint control of another entity (joint venture) with Braskem, or solely by holding an equity interest in Controlled Companies, Associates,
or Investee Companies of the Company.</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">In the event of any conflict
or questioning between the concept or scope of Related Parties defined in this Policy and that of the PCP 05(R1), as amended, the rules
of CPC 05(R1) or any other that may replace it will prevail.</P>

<P STYLE="color: #404040; font: 11pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.9pt"><FONT STYLE="font-size: 11pt">5.2</FONT></TD><TD><FONT STYLE="font-size: 11pt; text-transform: uppercase">IDENTIFICATION OF BRASKEM&rsquo;S RELATED PARTIES</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">The List of Related Parties
shall be made available to the Company&rsquo;s areas for prior consultation before entering into contracts or transactions of any nature
by any Company Member, who must identify and inform Braskem&rsquo;s Corporate Governance Area whenever such contracts or transactions
qualify as a Related Party Transaction.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">The List of Related Parties
is prepared and periodically updated based on the form completed by the controlling shareholder(s), shareholder(s) exercising Significant
Influence over the Company, and Key Persons of the controlling shareholder(s), Braskem, and its Controlled Companies, through which Braskem&rsquo;s
Corporate Governance Area identifies the Related Parties.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.9pt"><FONT STYLE="font-size: 11pt">5.3</FONT></TD><TD><FONT STYLE="font-size: 11pt; text-transform: uppercase">NEGOTIATION OF RELATED PARTY TRANSACTIONS</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">Related Party Transactions
may involve the transfer of resources, provision of services, purchase or sale of goods, or assumption of obligations, whether for consideration
or free of charge. Such transactions must be negotiated independently and transparently, under commutative conditions or with appropriate
compensatory payment. Whenever possible, potential alternatives to such transactions should be considered to ensure the Company&rsquo;s
best interest.</P>
<P STYLE="font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; color: #404040; margin: 6pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">Transactions must also be
supported by reasonable economic and business grounds, representing the best available alternative for Braskem and its Controlled Companies
at the time of execution. Related Party Transactions must be formalized in writing, specifying their key characteristics, terms, and other
relevant information.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">The Company shall establish
the appropriate processes and requirements to ensure that corporate restructuring transactions (such as mergers, consolidations, share
incorporations, transformations, and spin-offs), involving the Company and/or its Controlled Companies on one side, and Related Parties
on the other, are carried out under commutative conditions.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.9pt"><FONT STYLE="font-size: 11pt">5.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt; text-transform: uppercase">ANALYSIS AND GOVERNANCE FOR THE APPROVAL OF RELATED
PARTY TRANSACTIONS</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">The execution of any Related
Party Transaction must be preceded by review and approval, as applicable, by the General Shareholders&rsquo; Meeting, the Board of Directors,
or the Contracting Area, in accordance with the Company&rsquo;s Delegation of Authority Guideline and the provisions of this Policy.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">Any Related Party Transaction
subject to approval by the Board of Directors or reporting to the Corporate Governance Area, pursuant to this Policy, must be accompanied
by the corresponding Related Party Form prepared by the Contracting Area and reviewed by the respective legal support team. This form
must specify the key terms and conditions of the transaction, including a description of available market alternatives, the selection
process, and the rationale for choosing the Related Party, or the justification for the absence of a selection process, where applicable.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">The bodies or individuals
responsible for reviewing or approving Related Party Transactions under this Policy may request opinions, reports, and/or valuation assessments
from third parties (such as investment banks, law firms, accounting firms, among others), provided such third parties have no involvement
or interest in the Related Party Transaction in question, in order to clarify any doubts and/or support the decision-making process.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">Except as expressly permitted
by this Policy or by the Board of Directors, within its duties and responsibilities, no Related Party Transaction may be executed prior
to the completion of its approval as set forth herein, subject to the exemptions provided in this Policy.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">Additionally, without prejudice
to the treatment required under applicable laws and regulations, including disclosures in the financial statements, the following Related
Party Transactions entered into by the Company and/or any of its Controlled Companies shall not be subject to the approvals set forth
in this Policy and are exempt from reporting to the Corporate Governance Area, as applicable, provided they are carried out under commutative
conditions or with appropriate compensatory payment, and in accordance with the Delegation of Authority Guideline and other applicable
Company guidance documents:</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/17pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">Confidentiality agreements for
the receipt or disclosure of information, provided they do not contain other obligations, such as exclusivity or the execution of additional
contracts;</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/17pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">Letters of intent, memoranda
of understanding, or other non-binding preliminary instruments, provided they do not impose exclusivity obligations or otherwise restrict
the activities of the Company and/or any of its Controlled Companies; </FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/17pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">Sending and receiving product
samples up to an individual limit of R$50,000.00 (fifty thousand reais) per production batch, in accordance with the Company&rsquo;s guidance
documentation applicable to this type of transaction;</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/17pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">Transactions resulting from
compliance with administrative, judicial, or arbitral decisions; and</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 12pt/17pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Tahoma, Helvetica, Sans-Serif; font-size: 11pt">Transactions entered into between
Braskem and entities directly or indirectly controlled by Braskem on an individual basis (excluding joint control), as well as transactions
entered into between entities directly or indirectly controlled by Braskem on an individual basis (excluding joint control), shall be
exempted, except in cases where there is equity participation in the controlled entity by Braskem&rsquo;s controlling shareholder or by
Key Person(s) associated with the controlling shareholder.</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">The Board of Directors may,
upon justified grounds, determine that other Related Party Transactions shall not be subject to the approvals set forth in this Policy,
provided that such transactions are carried out under commutative conditions or with appropriate compensatory payment, and that, in their
approval process, alternative options to the execution of such transactions are considered whenever applicable.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.9pt"><FONT STYLE="font-size: 11pt">5.5</FONT></TD><TD><FONT STYLE="font-size: 11pt; text-transform: uppercase">PROHIBITIONS</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">Related Party Transactions
shall be prohibited when:</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">they are not in compliance with this Policy, Braskem&rsquo;s Bylaws, or applicable legislation; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">they constitute loans granted in favor of (i) the Company&rsquo;s controlling shareholder or (ii) Key
Persons of (a) the Company and/or (b) its controlling shareholder.</TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: bold 12pt/16pt Tahoma, Helvetica, Sans-Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.9pt"><FONT STYLE="font-size: 11pt">5.6</FONT></TD><TD><FONT STYLE="font-size: 11pt; text-transform: uppercase">DISCLOSURE OF RELATED PARTY TRANSACTIONS</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">For purposes of disclosing
the Financial Statements and the information contained in the Reference Form filed with the Brazilian Securities and Exchange Commission
(CVM), as well as in the disclosure of Notices regarding Related Party Transactions pursuant to CVM Resolution No. 80/22, the Company
shall apply the concepts and rules governing Related Parties as set forth in applicable laws and regulations.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">In any disclosures required by
applicable law or regulation, Braskem shall provide sufficient information to identify the Related Parties and the subject matter of the
Transaction, along with any other required information, in order to enable the Company&rsquo;s shareholders to monitor and assess management&rsquo;s
activities related to such transactions.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #404040; font: bold 12pt/17pt Tahoma, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.9pt"><FONT STYLE="font-size: 11pt">5.7</FONT></TD><TD><FONT STYLE="font-size: 11pt; text-transform: uppercase">SITUATIONS INVOLVING POTENTIAL CONFLICTS OF INTEREST</FONT></TD></TR></TABLE>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">A potential conflict of interest
arises when a shareholder, Member, or Key Person of the Company and/or its Controlled Entities is involved in a decision-making process
in which their ability to exercise objective and impartial judgment may be compromised due to: (i) having the power to influence the outcome
of the decision, and simultaneously (ii) the decision potentially resulting in a gain, benefit, or advantage for themselves, a Close Relative,
or a Third Party with whom the shareholder, Member, or Key Person of the Company and/or its Controlled Entities is involved (&ldquo;<B>Conflict
of Interest</B>&rdquo;).</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">Given the potential for Conflict
of Interest in such situations, the Company and its Controlled Entities shall seek to ensure that all decisions that may result in private
gains, benefits, or advantages not shared with the Company and/or its Controlled Entities, for any shareholder, Member, Key Person, Close
Relative, or related entities or individuals, are made with full transparency and in alignment with the best interests of the Company
and/or its Controlled Entities, as applicable.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">Within the scope of the Company&rsquo;s
general shareholders&rsquo; meetings, any Conflict of Interest involving a shareholder shall be addressed in accordance with Law No.
6,404/76, taking into account CVM guidance on the matter. If there is strong indication of a potential Conflict of Interest that may
lead to disqualification or invalidation of a vote, the chairperson of the shareholders&rsquo; meeting shall inquire the shareholder
and remind them of their responsibilities, leaving it to the shareholder to assess the existence of a conflict and determine whether
they are disqualified from participating in the resolution.</P>
<P STYLE="font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; color: #404040; margin: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">Furthermore, without prejudice
to the rules set forth in the Company&rsquo;s guiding documents addressing Conflicts of Interest, Members and Key Persons of the Company
and/or its Controlled Entities who identify the possibility of participating in a decision-making process involving a potential conflict
must disclose such potential conflict to their Leader or to the other members of the competent body, as applicable. Additionally, such
Members and Key Persons must refrain from participating in discussions on the matter and must abstain from negotiating, evaluating, expressing
opinions, approving, voting, or otherwise influencing the handling or approval of the respective matter within the Company and/or its
Controlled Entities, as applicable.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">If requested by the members of
the competent body, Key Persons in a Conflict of Interest situation may participate in discussions to provide further information regarding
the matter and the parties involved, but must withdraw from the remainder of the discussion and the voting process.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">If any Member or Key Person of
the Company and/or its Controlled Entities stands to obtain a private gain, benefit, or advantage not shared with the Company and fails
to disclose such situation, any other person aware of the matter must do so. The Member&rsquo;s Leader or the competent body shall then
assess the situation collectively.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">Any disclosure regarding the
characterization of a potential Conflict of Interest and the resulting abstention from voting by the Key Person must be recorded in the
minutes of the respective meeting.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">Without prejudice to the foregoing,
in situations where a Conflict of Interest involving any Member or Key Person of the Company and/or its Controlled Entities is identified
and disclosed, the rules set forth in the Company&rsquo;s guiding documents on Conflicts of Interest and other applicable governance documents
of Braskem must also be observed.</P>

<P STYLE="color: #404040; font: 11pt/17pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: bold 12pt/115% Tahoma, Helvetica, Sans-Serif; margin: 12pt 0 3pt; text-indent: 0in"><FONT STYLE="font-size: 11pt">6.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11pt; text-transform: uppercase">GENERAL PROVISIONS</FONT></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">Members are responsible for
knowing and understanding all applicable Guiding Documentation. Likewise, Leaders are responsible for ensuring that their team members
understand and comply with the Company&rsquo;s applicable Guiding Documentation.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">Members who have questions
regarding this Policy, including its scope, terms, or obligations, should contact their Leader or Braskem&rsquo;s Corporate Governance
department.</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/16pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">If any Member or Third Party
becomes aware of a potential violation of this Policy, they must immediately report the suspected violation through the Ethics Line Channel.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">Violations of any of the
Company&rsquo;s Guiding Documentation may result in serious consequences for Braskem and the Members involved. Therefore, failure to comply
with this Policy or failure to report a violation may result in disciplinary action against the Member(s) involved.</P>

<P STYLE="color: #404040; font: 11pt/115% Tahoma, Helvetica, Sans-Serif; margin: 0 0 10pt"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: 11pt/115% Tahoma, Helvetica, Sans-Serif; margin: 0 0 10pt"><B>Braskem Board of Directors<BR STYLE="clear: both">
</B></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: gray; font: bold 12pt/115% Tahoma, Helvetica, Sans-Serif; margin: 24pt 0 3pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="color: #404040; font: bold 11pt/115% Tahoma, Helvetica, Sans-Serif; margin: 24pt 0 3pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">DEFINITIONS</FONT></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">Below are the definitions
of the capitalized terms used in this Policy:</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&ldquo;<B>Managers</B>&rdquo;:
members on the Board of Directors and Statutory Board of Executive Officers.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Contracting Area&rdquo;</B>:
the department that initiates or intends to engage in a Related Party Transaction.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Braskem&rdquo;
ou &ldquo;Company&rdquo;</B>: Braskem S.A.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Affiliate&rdquo;</B>:
an entity over which a person has Significant Influence without exercising Control.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Statutory Compliance
and Audit Committee&rdquo; or &ldquo;CCAE&rdquo;</B>: a statutory and permanent advisory body to Braskem&rsquo;s Board of Directors, with
responsibilities set forth in its Internal Regulations and subject to Law No. 6,404/76, CVM Resolution No. 23/21, and the Sarbanes-Oxley
Act.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Board of Directors&rdquo;
ou &ldquo;BoD&rdquo;: </B>Board of Directors of Braskem S.A.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Controlled Company(ies)&rdquo;:</B>
entities in which Braskem, directly or through other Controlled Companies, holds rights that permanently ensure dominance in corporate
resolutions and the power to appoint the majority of the Managers.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;CPC-05 (R1)&rdquo;</B>:
Technical Pronouncement issued by the Brazilian Accounting Pronouncements Committee, approved by CVM Resolution No. 642/2010, regarding
required disclosures in the balance sheet and income statement related to transactions and balances with related parties.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Delegation of Authority
Guideline&rdquo;</B>: guiding document of the Company that establishes approval levels for transactions and commitments with third parties,
based on position and geographic region where the Company and its Controlled Companies operate.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&ldquo;<B>ESG</B>&rdquo;:
acronym for Environmental, Social, and Governance, referring to the adoption of best practices in these areas.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Related Party
Transaction Form&rdquo;:</B> a form made available by the Corporate Governance department through the Company&rsquo;s internal systems,
to be completed and submitted by the Requesting Areas to support the review of the terms and conditions of Related Party Transactions
by the CCAE and the BoD, or to report Related Party Transactions that, due to their value, fall within the scope of the Company&rsquo;s
Delegation of Authority Guideline.</P>
<P STYLE="font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; color: #404040; margin: 6pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&ldquo;<B>GC</B>&rdquo;:
the Company&rsquo;s Corporate Governance department.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Significant Influence&rdquo;:</B>
the power to participate in the financial and operating policy decisions of an entity without having control over those policies. Significant
Influence may be obtained through equity interest, statutory provisions, or shareholder agreements. When an investor holds, directly or
indirectly, twenty percent or more of the voting power of an investee, it is presumed to have Significant Influence, unless clearly demonstrated
otherwise. Conversely, if the investor holds less than twenty percent, it is presumed not to have influence. Evidence of Significant Influence
may include: (a) representation on the board of directors or executive management of the investee; (b) participation in policy-making
processes, including decisions on dividends and other distributions; (c) material transactions between the investor and the investee;
(d) interchange of managerial personnel; (e) provision of essential technical information.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Member&rdquo;:</B>
any individual working at Braskem and/or any of its Controlled Entities, at any level, including employees, executives, board members,
directors, interns, and apprentices (as applicable in each geographic location).</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Key Persons&rdquo;:
</B>individuals who have authority and responsibility for planning, directing, and controlling the activities of the entity, directly
or indirectly, including any Manager (executive or non-executive) of the entity.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Close Relative&rdquo;:</B>
family members who may be expected to influence or be influenced by the individual in their dealings with the entity, including: (a) the
individual&rsquo;s children, spouse or partner; (b) the children of the individual&rsquo;s spouse or partner; and (c) dependents of the
individual, their spouse or partner.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;CVM Resolution
No. 80/22&rdquo;:</B> refers to CVM Resolution No. 80, dated March 29, 2022.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Third Party(ies)&rdquo;</B>:
any individual or legal entity that is not a Member and acts on behalf of, in the interest of, or for the benefit of Braskem and/or any
of its Controlled Entities, provides services or supplies goods, or is a business partner directly involved in obtaining, retaining, or
facilitating business, or in conducting affairs of Braskem and/or such Controlled Entities, including, without limitation, distributors,
agents, brokers, customs brokers, intermediaries, supply chain partners, consultants, resellers, contractors, and other professional service
providers.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><IMG SRC="bak202508146k_003.jpg" ALT="">&nbsp;</TD></TR></TABLE><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify"><B>&ldquo;Related Party Transaction(s)&rdquo;
or &ldquo;Transaction(s)&rdquo;:</B> any transaction that results in the transfer of resources, services, or obligations between, on one
side, the Company and/or any of its Controlled Entities, and on the other, any Related Parties of Braskem, regardless of whether a price
is charged in return.</P>

<P STYLE="color: #404040; font: 11pt/16pt Tahoma, Helvetica, Sans-Serif; margin: 6pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: left; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Date: August 15, 2025</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>BRASKEM S.A.</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 46%; font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 43%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Felipe Montoro Jens</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Felipe Montoro Jens</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DISCLAIMER ON FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0 0 3pt; text-align: justify; background-color: white">This
report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
1995. These statements are statements that are not historical facts, and are based on our management&rsquo;s current view and estimates
of future economic and other circumstances, industry conditions, company performance and financial results, including any potential
or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial
condition and operating results. The words &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo;
&ldquo;plans&rdquo; and similar expressions, as they relate to the company, are intended to identify forward-looking statements.
Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and
financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our
financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the
current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control.
There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions
and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such
assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the
unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders,
could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the
year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each
of which is available on the SEC&rsquo;s website (www.sec.gov), for a full discussion of the risks and other factors that may impact
any forward-looking statements in this presentation.</P>
<HR SIZE="2" NOSHADE ALIGN="LEFT" COLOR="Black" STYLE="width: 100%">
<P STYLE="font: 11pt Tahoma, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #7F7F7F"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/150% Tahoma, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify; color: #7F7F7F">&nbsp;</P>

<P STYLE="font: 11pt/150% Tahoma, Helvetica, Sans-Serif; margin: 12pt 0 0; text-align: justify; color: #7F7F7F">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>bak202508146k_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bak202508146k_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2< X$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"EJ^I1Z
M1I-SJ$HS' F]AG_ZQKAO^%OZ3_SP_P#'W_\ B*Z3QY_R(VL?]>Y_F*^:Z]?
M82G6@Y3[GE8[%5*,TH=CW#_A;^D_\\/_ !]__B*/^%OZ3_SP_P#'W_\ B*\/
MHKO_ +-H=C@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z
M*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-
MH=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_
MM&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW
M/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^
M%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3
M_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \
M/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W
M_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B
M*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\
MA;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D
M_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/
M#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]
M_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#X
MBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z
M*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-
MH=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_
MM&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW
M/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^
M%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3
M_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \
M/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W
M_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B
M*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\
MA;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D
M_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/
M#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]
M_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#X
MBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z
M*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-
MH=@_M&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_
MM&OW/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW
M/</^%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^
M%OZ3_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3
M_P \/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \
M/_'W_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W
M_P#B*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B
M*/\ A;^D_P#/#_Q]_P#XBO#Z*/[-H=@_M&OW/</^%OZ3_P \/_'W_P#B*/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OI_PK_R)^B?
M]>$'_HM:^8*^G_"O_(GZ)_UX0?\ HM:\?-O@CZ_H>OE?QR]/U->BBBO /="B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YWQY_R(VL?]>Y_F*^:Z
M^E/'G_(C:Q_U[G^8KYKKZ'*OX4O7]#P,T_B1]/U"BBBO6/*"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OI_PK_R)^B?]
M>$'_ *+6OF"OI_PK_P B?HG_ %X0?^BUKQ\V^"/K^AZ^5_'+T_4UZ***\ ]T
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G?'G_ "(VL?\ 7N?Y
MBOFNOI3QY_R(VL?]>Y_F*^:Z^ARK^%+U_0\#-/XD?3]0HHHKUCR@HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZ?\*_\
M(GZ)_P!>$'_HM:^8*^G_  K_ ,B?HG_7A!_Z+6O'S;X(^OZ'KY7\<O3]37HH
MHKP#W0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .=\>?\B-K'_7
MN?YBOFNOI3QY_P B-K'_ %[G^8KYKKZ'*OX4O7]#P,T_B1]/U"BBBO6/*"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHHKUCR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KZ?\ "O\ R)^B?]>$'_HM:^8*^G_"O_(GZ)_UX0?^BUKQ\V^"/K^A
MZ^5_'+T_4UZ***\ ]T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#G?'G_(C:Q_U[G^8KYKKZ4\>?\B-K'_7N?YBOFNOH<J_A2]?T/ S3^)'T_4*
M***]8\H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *^G_"O_(GZ)_UX0?^BUKY@KZ?\*_\B?HG_7A!_P"BUKQ\V^"/K^AZ
M^5_'+T_4UZ***\ ]T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MG?'G_(C:Q_U[G^8KYKKZ4\>?\B-K'_7N?YBOFNOH<J_A2]?T/ S3^)'T_4**
M**]8\H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *^G_"O_(GZ)_UX0?\ HM:^8*^G_"O_ ")^B?\ 7A!_Z+6O'S;X(^OZ
M'KY7\<O3]37HHHKP#W0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M .=\>?\ (C:Q_P!>Y_F*^:Z^E/'G_(C:Q_U[G^8KYKKZ'*OX4O7]#P,T_B1]
M/U"BBBO6/*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "OI_PK_P B?HG_ %X0?^BUKY@KZ?\ "O\ R)^B?]>$'_HM:\?-
MO@CZ_H>OE?QR]/U->BBBO /="BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH YWQY_R(VL?]>Y_F*^:Z^E/'G_ "(VL?\ 7N?YBOFNOH<J_A2]?T/
MS3^)'T_4****]8\H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK>\*^&)/
M$E[,&N$M;&U3S;JY?I&G^/!_(UKKI?@*]F:RM-:U.VGZ)=7D:?9V/X ,H]SC
M%82KQC+EU=M[*]C>-"4DI:*_=VN<5176>'_"-O>:9<ZUK5_]BTBWD\OS(UW/
M,WHGM[\_SQ?T[PYX/\2N]EHFI:G::D5)ACU%8RLA'.!L_'OGV.*4L1"+>^F[
MMHAQPTW;;7;75G"45UGA#PI#K/BJYT?5FN(/LT4C2"%E#!D(&,D$=S6CIGAC
MPIXI^T6>@7NK6^I)&9(TU!8RD@';Y.GY]^AQ1/$PBVG?2W334(8><DFK:WZZ
MZ'!45UG@_P .:9J]MK5UK#WL<6FP"8K:E0Y^]D?,#S\OM5S_ (1;P_KNA7][
MX8O-1^U6">;+:WRIN=.<E2@QV/KTQQFB6(A&3B[Z6UMIJ$</.44U;6_KH</1
M76Z%X4L9=#.O^(;][+2S)Y<*Q+NEG;OM].A['H>@%7K#POX7\3I+;^'=1U&#
M4T4O';ZBJ8E ]"G _P \42Q,(M[V6[MH$<-.5MKO97U.$HKK?!GA:SUS4M3@
MU9[J%+&W:5EMRH?<IP1R"/6K]EX6\,>)K*\'AR^U.+4+:(S>1J"QGS%'ILZ>
MGXCBB6)A%M.^ENFFH1PTY)-6UOUUT.#HJ[I&G2:MJ]II\6=]Q*L>0.@)Y/X#
MFNE\;^$M/T"WL[S2+F>YLI9)8)'F925E1L$< >A_*KE5C&:@]V1&E*4'-;(X
MVBNMT"S\&:BUA8WC:\-1N9$A8P^2(@[-@8SSCD59\1Z5X+T2[O\ 34?7WU"W
M4JC$PF(OMRN> =N2,\9J/;KGY+._I_P2O8/EY[JWK_P#B:*]!U7PWX.\/6>F
M-JDNNR3WEJL_^BF$J,@9^\ 1S]:XW5_[(^W?\27[;]DVC_C]V>9N[_=XQTJJ
M=95/A3MZ"J494])-7]2A175>!O#=AXCO+]=1EN8X+6U,_P#HY4,<$?W@1TS6
MC:>%O#/B6QO/^$;O=334;:(RBVOUC_>J/[I3IZ=?PJ9XB$).+OI:^FFI4,/.
M44U;7;770X2BNJ\.>$[>_P!)GUS6KYK#2('\O>J9DE;T0?CUY_GC1T[PYX/\
M2N]EHFI:G::D5)ACU%8RLA'.!L_'OGV.*)8B$6]]-]-$$</.26VNVNK.$HKJ
M_"/A2+6?%%WH^J&>!K:*1F$+ ,'0@8R01CDURE:QJ1E)Q72WXF4J<HQ4GUO^
M 45U/B[PS:Z$-&%B]Q*]]:+,ZR$,=YQPN ..?>M"[\+>'/#-O!'XGO\ 4)-2
MF4.;73E3,*G^\7X/?_/-9?6(-)K6^VFIJ\/--IZ6WUT.&HKN=/\ #'A:_P#$
MEI90ZU//97\3B!EVI+#*.BR @\'G'3-9>B^$+G4/&AT"ZW1>1(WVEU_A1>I&
M?7C!_P!H4_K$-;Z65P>'GI;6[L<U15W5X[&'5[J+3))9+))"L3RD%F XSD #
MGK]*I5LG=7,&K.P4444Q!7T_X5_Y$_1/^O"#_P!%K7S!7T_X5_Y$_1/^O"#_
M -%K7CYM\$?7]#U\K^.7I^IKT445X![H4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '.^//^1&UC_KW/\Q7S77TIX\_Y$;6/^O<_S%?-=?0Y5_"E
MZ_H>!FG\2/I^H4445ZQY04444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'H/AW
MS%^$7B=K?/G&= ^.NS*9_0M7GU=#X3\4/X;NIUEMUN].NT\JZMFZ.OJ/<9/U
MS^(TQJ?@*RG:\L]'U2ZFZQVMY(GD*?P)8CV.<UQQYJ4Y^ZW=W5O38[)<M6$/
M>2LK._YEWQ JK\'O#7D_ZHW+E\=-^7Z_K7,^#_._X3+1O(SO^V19Q_=W#=^F
M:U-!\7V=OI-QH>NZ>;S29I#*BPG:\#9S\OM^([^M6['Q)X3\-%KS0--U&YU/
M:1%-J3)MBR,9 0\_S]ZA*<(2I\K;;=NVO^1HW"<XU.9))*_?3_,ZC13&?C9K
MI7[GV=P<>N$S^N:I^&UT*RT75M7\'QW=QJMM <IJ+#?&AZLJH,-T_3WYY+P?
MXIAT3Q+=:MJ8GG-Q#(K&)5+%W(.3D@=C5;P9XA3PSXBCOID>2V9&BG1 "S(1
MVR0.H!_"LI8:=I)=%'T=MT:1Q,+Q;ZN7JK[,Z/X<)#<:-XM2[N3!#)9 2SE"
M^P$/EL#DXZXJ*WU?PYX1T+4H-%U*?5=2U"'R#,;<PQQ*<\X;G//OT'2L_2?$
M>E:1;^*+:&&Z,&IPM%:#8N4!W8W_ #<8W#IGI7(ULJ#G.3E=)VT[Z&+KJ$(J
M-FU?7MJ>@>-@X\ >#1%G[/Y#E\=-^%_7[WZUC?#S?_PGND^7G/F-T]-C9_3-
M6=$\6:</#Q\/>(["6[T]&+P2P$"6%B>V< ]3W[XY'2U9^*?#?AB&:;PSI]_+
MJ4JE%NM29/W(/7:$X/\ GGM4VG&G*ERMMWL^FO\ PY5X2J1J\UDK:==#H_"S
M6S>/O&A^;[/Y<^_R^N-_S8SWZU4TS^R-.\':QJW@Q+B:^5/*N6U!E\Z"(]2J
MJ-IZ9Z]N^,5RW@_Q/;:#<:M-?K<3/>VKPJT8#'>3G+$D?GS4?@KQ+#X;U::2
M\BDFL+F%H;B*, D@]" 2 >>.O0FLYX>=Y-:VY=.CLM32.(A:-]+\WJK[&U\+
MM*NIK[4=8MK;SYK&V9;9"0H>9@0!N/ XSGZUM6/A+Q ?A_K>E:S9.DJ/]MM'
M:=)"S@98<$XSC\=QKD+OQ#IL7@?_ (1_3([H22WC3W$LRJ Z G8.&/. F>.H
M-4_!WB!?#/B2#4)5=[<*T<R1@%F0CMG'?!_"JJ4JL^:HM[JRZZ;=>NI,*M*'
M+3>UG=]-=^G30K^%_P#D;=%_Z_X/_1BUH?$'_D?-7_ZZC_T$50M]0L;/Q?#J
M5O'*+"&^6X2/: XC#AMN,XSCCK2^*=5@UOQ-?:E;)(D-PX95D # 8 YP2.WK
M759NLI6TM^J.6Z5%QOK?]&>A>,_^$9^Q>'O[>_M?S?[/3R_L/E[=N!UW]Z\O
MU'[!]OF_LS[3]BS^Z^T[?,QC^+;QUSTKM]5\2>#O$-GIBZI%KL<]G:K!_HHA
M"G &?O$D\_2N.UC^R/MH_L3[=]DV#/VW9OW<Y^[QCI6.$BX+EDG?7TW-L7*,
MY.46K:>NQV?PG5'O=;623RXSI[!GQG:,C)QWIFFZGX9\%VE]<Z5JDNL:K<0F
M")OLS0QQ*>I(;KR!T^G')K'\&>)+/PY)JC7<4\GVJT:"/RE!PQ]<D<5R]-T'
M.K/FO9V^8>W4*4.6UU?Y'H/B!57X/>&O)_U1N7+XZ;\OU_6N9\'^=_PF6C>1
MG?\ ;(LX_N[AN_3-:7AWQ;9VFBS:!KM@U]I,C^8@C;;)"WJO_P"L=_6KMCXD
M\)^&BUYH&FZC<ZGM(BFU)DVQ9&,@(>?Y^]2E.$9T^5N[=NVHVX3E"IS)62OW
MT.GT8H?C5KQ3&/L[CCUPF?US7CU=5X-\4P:)XGN-6U47$XN(I%D,*J6+.02<
M$@=C4=]_P@_V&;^S_P#A(?M>T^5]H\CR]W^UCG'TITHRI3::;TBK^@JLHU8)
MII:R?WG::^L3>*O (FQL\F#KZY7'ZXKC/B(7/C[5O,SN\Q<9]-BX_3%/\6>*
M+;6SHK6"W$,FGVJQ,T@"G>,<K@GCCVK2OO%/ACQ1%#/XDT_48=2C4(]QIS)B
M4#U#\#]?K6=&$Z7+)Q>S7FM;FM:I"KS14ENGZZ6.&AEDMYXYHG*21L'1AU!!
MR#7KFOZ_;1^!SXELX3%J>NQ)9RNHQM*;@Y'Y$9]E]*\Z\0:CI-Z]O#HVE_8K
M6!2-SMNEE)QDN?;' [5;U#Q#:7?@+2-"CCF%U9SR22.P&PAF8C!SG^(=A6M6
MFZKA)KKKZ>?S2,:53V2G%2Z:>OE\FSFJ***[3B"BBB@ KZ?\*_\ (GZ)_P!>
M$'_HM:^8*^G_  K_ ,B?HG_7A!_Z+6O'S;X(^OZ'KY7\<O3]37HHHKP#W0HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** .=\>?\B-K'_7N?YBOFNO
MI3QY_P B-K'_ %[G^8KYKKZ'*OX4O7]#P,T_B1]/U"BBBO6/*"BBB@ HHHH
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M_P B?HG_ %X0?^BUKQ\V^"/K^AZ^5_'+T_4UZ***\ ]T**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#G?'G_ "(VL?\ 7N?YBOFNOI3QY_R(VL?]
M>Y_F*^:Z^ARK^%+U_0\#-/XD?3]0HHHKUCR@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZ?\*_\ (GZ)_P!>$'_HM:^8
M*^G_  K_ ,B?HG_7A!_Z+6O'S;X(^OZ'KY7\<O3]37HHHKP#W0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .=\>?\B-K'_7N?YBOFNOI3QY_P B
M-K'_ %[G^8KYKKZ'*OX4O7]#P,T_B1]/U"BBBO6/*"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OI_P *_P#(GZ)_UX0?
M^BUKY@KZ?\*_\B?HG_7A!_Z+6O'S;X(^OZ'KY7\<O3]37HHHKP#W0HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** .=\>?\B-K'_7N?YBOFNOI3QY_
MR(VL?]>Y_F*^:Z^ARK^%+U_0\#-/XD?3]0HHHKUCR@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^G_"O_ ")^B?\
M7A!_Z+6OF"OI_P *_P#(GZ)_UX0?^BUKQ\V^"/K^AZ^5_'+T_4UZ***\ ]T*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G?'G_(C:Q_U[G^8KYK
MKZ4\>?\ (C:Q_P!>Y_F*^:Z^ARK^%+U_0\#-/XD?3]0HHHKUCR@HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZ?\ "O\
MR)^B?]>$'_HM:^8*^G_"O_(GZ)_UX0?^BUKQ\V^"/K^AZ^5_'+T_4UZ***\
M]T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G?'G_(C:Q_U[G^8
MKYKKZ4\>?\B-K'_7N?YBOFNOH<J_A2]?T/ S3^)'T_4****]8\H**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^G_"O_(G
MZ)_UX0?^BUKY@KZ?\*_\B?HG_7A!_P"BUKQ\V^"/K^AZ^5_'+T_4UZ***\ ]
MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G?'G_(C:Q_U[G^8K
MYKKZ4\>?\B-K'_7N?YBOFNOH<J_A2]?T/ S3^)'T_4****]8\H**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^G_"O_(GZ
M)_UX0?\ HM:^8*^G_"O_ ")^B?\ 7A!_Z+6O'S;X(^OZ'KY7\<O3]37HHHKP
M#W0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .=\>?\ (C:Q_P!>
MY_F*^:Z^E/'G_(C:Q_U[G^8KYKKZ'*OX4O7]#P,T_B1]/U"BBBO6/*"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OI_PK
M_P B?HG_ %X0?^BUKY@KZ?\ "O\ R)^B?]>$'_HM:\?-O@CZ_H>OE?QR]/U-
M>BBBO /="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YWQY_R(VL
M?]>Y_F*^:Z^E/'G_ "(VL?\ 7N?YBOFNOH<J_A2]?T/ S3^)'T_4****]8\H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KZ?\*_\ (GZ)_P!>$'_HM:^8*^G_  K_ ,B?HG_7A!_Z+6O'S;X(^OZ'
MKY7\<O3]37HHHKP#W0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M.=\>?\B-K'_7N?YBOFNOI3QY_P B-K'_ %[G^8KYKKZ'*OX4O7]#P,T_B1]/
MU"BBBO6/*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "OI_P *_P#(GZ)_UX0?^BUKY@KZ?\*_\B?HG_7A!_Z+6O'S;X(^
MOZ'KY7\<O3]37HHHKP#W0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** .=\>?\B-K'_7N?YBOFNOI3QY_R(VL?]>Y_F*^:Z^ARK^%+U_0\#-/XD?3
M]0HHHKUCR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KZ?\ "O\ R)^B?]>$'_HM:^8*^G_"O_(GZ)_UX0?^
MBUKQ\V^"/K^AZ^5_'+T_4UZ***\ ]T**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#G?'G_(C:Q_U[G^8KYKKZ4\>?\B-K'_7N?YBOFNOH<J_A2]?
MT/ S3^)'T_4****]8\H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *^G_"O_(GZ)_UX0?^BUKY@KZ?\*_\B?HG_7A!_P"B
HUKQ\V^"/K^AZ^5_'+T_4UZ***\ ]T**** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>bak202508146k_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bak202508146k_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !_ P$# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.%OX@TZ:65456E@5'$QYR64E0O;ID=>G2B?XSVUO<B/3]"+62+A1),(V)X[
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MS\4_\)=K$-_]C^R>7;B'9YOF9PS'.<#^]^E8EG:2WUVEM"!O?/+'   R2?8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *]%^$/_ ",,OX?^@25YU7HOPA_Y&&7\/_0)*Y,9_ D=6#_CQ/<:***^
M3/JCQ;XT_P#(=TW_ *]C_P"A&O,J^C/%7@33_%EY!<WES=1-#'Y:B$J 1G/.
M0:P?^%,:'_T$-1_[Z3_XFO>PV.HTZ,82>J\CP\3@JU2K*<5H_,\1HKV[_A3&
MA_\ 00U'_OI/_B:/^%,:'_T$-1_[Z3_XFNC^TL/W?W'/_9U?LOO/$:*]N_X4
MQH?_ $$-1_[Z3_XFC_A3&A_]!#4?^^D_^)H_M+#]W]P?V=7[+[SQ&BO;O^%,
M:'_T$-1_[Z3_ .)H_P"%,:'_ -!#4?\ OI/_ (FC^TL/W?W!_9U?LOO/$:*]
MN_X4QH?_ $$-1_[Z3_XFC_A3&A_]!#4?^^D_^)H_M+#]W]P?V=7[+[SQ&BO;
MO^%,:'_T$-1_[Z3_ .)H_P"%,:'_ -!#4?\ OI/_ (FC^TL/W?W!_9U?LOO/
M$:*]N_X4QH?_ $$-1_[Z3_XFC_A3&A_]!#4?^^D_^)H_M+#]W]P?V=7[+[SQ
M&BO;O^%,:'_T$-1_[Z3_ .)H_P"%,:'_ -!#4?\ OI/_ (FC^TL/W?W!_9U?
MLOO/$:*]N_X4QH?_ $$-1_[Z3_XFC_A3&A_]!#4?^^D_^)H_M+#]W]P?V=7[
M+[SQ&BO;O^%,:'_T$-1_[Z3_ .)H_P"%,:'_ -!#4?\ OI/_ (FC^TL/W?W!
M_9U?LOO/$:*]N_X4QH?_ $$-1_[Z3_XFC_A3&A_]!#4?^^D_^)H_M+#]W]P?
MV=7[+[SQ&BO;O^%,:'_T$-1_[Z3_ .)H_P"%,:'_ -!#4?\ OI/_ (FC^TL/
MW?W!_9U?LOO/$:*]N_X4QH?_ $$-1_[Z3_XFC_A3&A_]!#4?^^D_^)H_M+#]
MW]P?V=7[+[SQ&BO;O^%,:'_T$-1_[Z3_ .)H_P"%,:'_ -!#4?\ OI/_ (FC
M^TL/W?W!_9U?LOO/$:*]N_X4QH?_ $$-1_[Z3_XFC_A3&A_]!#4?^^D_^)H_
MM+#]W]P?V=7[+[SQ&BO;O^%,:'_T$-1_[Z3_ .)H_P"%,:'_ -!#4?\ OI/_
M (FC^TL/W?W!_9U?LOO/$:*]N_X4QH?_ $$-1_[Z3_XFC_A3&A_]!#4?^^D_
M^)H_M+#]W]P?V=7[+[SQ&BO;O^%,:'_T$-1_[Z3_ .)H_P"%,:'_ -!#4?\
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M^)H_M+#]W]P?V=7[+[SQ&O1?A#_R,,OX?^@25U/_  IC0_\ H(:C_P!])_\
M$UM^&OA_IOA>]:ZM+JZE=L<2E2.A'8#^\:PQ..HU*4HQ>K\C?#X&M3JJ4EHO
*,ZVBBBO /=/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
